Neuroendocrine Regulation of Biliary Growth and Fibrosis

胆道生长和纤维化的神经内分泌调节

基本信息

项目摘要

In cholestatic liver diseases, cholangiocytes, through the secretion of neuroendocrine factors, are the key link between bile duct injury and the subepithelial fibrosis that characterizes chronic hepatobiliary injury. Targeting the factors that respond to the mechanical stress resulting from tissue injury may limit inflammation and liver fibrosis that occur in hepatobiliary damage and diseases such as primary biliary cirrhosis (PBC), primary sclerosing cholangitis (PSC) and liver fibrosis. Although mechanical stress occurs with biliary distention (commonly observed in PSC and extrahepatic cholestasis) and activates cholangiocytes, the cellular and molecular mechanisms responsible for this activated neuroendocrine phenotypes remain unclear. While advances have been made to further our understanding of the paracrine and autocrine neuroendocrine factors that modulate biliary proliferation during cholestasis, unfortunately, viable therapies for management of cholangiopathies remain elusive. There remains, therefore, a critical need to understand the triggers of cholangiocyte growth and their responses to damage during cholestasis, which may help identify key signaling pathways that represent viable targets for the development of effective therapeutic agents. Preliminary data from the analysis of the activated neuroendocrine cholangiocyte phenotypes demonstrated that: (i) cholangiocytes express serotonin receptors (5-HTR) (2A, 2B and 2C); (ii) mechanical stress-dependent activation of 5-HTR2B stimulates 5-HT synthesis and secretion and an activated neuroendocrine cholangiocyte phenotype in a PKA and miR-16 mediated mechanism; (iii) activation of mechanosensitive 5-HTR2B signaling in concert with increased cholangiocyte expression and secretion of FGF1 (regulated by miR-16) stimulates biliary proliferation during in vitro mechanical stress and bile duct ligation (BDL). Based upon these findings, we propose the overall central hypothesis that the mechanosensitive 5-HTè5-HTR2A/BCèFGF1 signaling axis is a key pathway responsible for mediating the proliferative and profibrogenic cholangiocyte phenotype. This postulate will be tested in three specific aims, which will demonstrate that: (i) mechanical stress-dependent 5-HT synthesis and release induces an activated neuroendocrine and profibrogenic cholangiocyte phenotype mediated by activation of 5-HTR2A/B/C receptor family; (ii) FGF1 secretion by cholangiocytes during cholestasis mediates biliary proliferation and the activated neuroendocrine cholangiocyte phenotype in a 5-HTR2A/B/C receptor family and miR-16- dependent autocrine/paracrine mechanism; and (iii) inhibition of the 5-HTR2A/B/CèFGF1 axis attenuates the activated neuroendocrine biliary phenotype and fibrosis during cholestasis. Completion of proposed studies will provide a framework for understanding how mechanical stimuli trigger local and systemic responses mediate hepatobiliary fibrosis.
在胆固性肝病中,通过神经内分泌因子的分泌,胆管细胞是关键 胆管损伤与特征慢性肝损伤的下层纤维化之间的联系。 针对响应组织损伤导致的机械应力的因素可能会限制 在肝胆管损伤中发生的炎症和肝纤维化和诸如原发性胆道等疾病 肝硬化(PBC),原发性硬化性胆管炎(PSC)和肝纤维化。尽管机械应力发生 胆道距离(通常在PSC和e骨外胆汁淤积中观察到)并激活 胆管细胞,该激活神经内分泌的细胞和分子机制 表型仍然不清楚。尽管已经取得了进步来进一步了解我们对旁分泌的理解 不幸的是 可行的胆管病治疗疗法仍然难以捉摸。因此,仍然存在关键 需要了解胆管细胞生长的诱因及其对胆汁淤积期间损伤的反应, 这可能有助于确定代表可行目标开发的关键信号通路 有效的治疗剂。来自激活神经内分泌的分析的初步数据 胆管细胞表型表明:(i)胆管细胞表达5-羟色胺受体(5-HTR)(2a,2b 和2C); (ii)5-HTR2B的机械应力依赖性激活刺激5-HT的合成和分泌,并且 PKA和miR-16介导的机制中活化的神经内分泌胆管细胞表型; (iii) 机械敏感的5-HTR2B信号传导的激活,随着胆管细胞的表达增加和 FGF1的分泌(由miR-16调节)在体外机械应力和 胆管连接(BDL)。基于这些发现,我们提出了总体中心假设 机械敏感的5-HTè5-htr2a/bcèfgf1信号轴是负责介导的关键途径 增殖和纤维化胆管细胞表型。该假设将以三个特定目的进行测试: 这将证明:(i)机械应力依赖性5-HT合成并释放会诱导 活化的神经内分泌和纤维化胆管细胞表型,通过5-HTR2A/B/C的激活介导 受体家族; (ii)胆汁淤积过程中胆管细胞分泌的FGF1分泌介导胆道增殖和 5-HTR2A/B/C受体家族中的活化神经内分泌胆管细胞表型和miR-16-- 依赖的自分泌/旁分泌机制; (iii)抑制5-Htr2a/b/cèfgf1轴可减弱 激活的神经内分泌胆道表型和纤维化期间的纤维化。拟议研究的完成 将提供一个框架,以了解机械刺激如何触发本地和全身响应 介导肝纤维纤维化。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Gianfranco D Alpini其他文献

Gianfranco D Alpini的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('Gianfranco D Alpini', 18)}}的其他基金

Regulation of Ductular Reaction by Substance P during Alcohol-induced Liver Injury
P物质对酒精性肝损伤过程中小管反应的调节
  • 批准号:
    10592570
  • 财政年份:
    2023
  • 资助金额:
    $ 28.99万
  • 项目类别:
Role of Sensory Innervation in High Fat Diet-Induced Hepatotoxicity
感觉神经支配在高脂肪饮食引起的肝毒性中的作用
  • 批准号:
    10467095
  • 财政年份:
    2022
  • 资助金额:
    $ 28.99万
  • 项目类别:
Role of Sensory Innervation in High Fat Diet-Induced Hepatotoxicity
感觉神经支配在高脂肪饮食引起的肝毒性中的作用
  • 批准号:
    10596643
  • 财政年份:
    2022
  • 资助金额:
    $ 28.99万
  • 项目类别:
Alcohol-induced hepatotoxicity - implications of secretin/secretin receptor axis
酒精引起的肝毒性 - 促胰液素/促胰液素受体轴的影响
  • 批准号:
    10252062
  • 财政年份:
    2020
  • 资助金额:
    $ 28.99万
  • 项目类别:
Alcohol-induced hepatotoxicity - implications of secretin/secretin receptor axis
酒精引起的肝毒性 - 促胰液素/促胰液素受体轴的影响
  • 批准号:
    10457005
  • 财政年份:
    2020
  • 资助金额:
    $ 28.99万
  • 项目类别:
Alcohol-induced hepatotoxicity - implications of secretin/secretin receptor axis
酒精引起的肝毒性 - 促胰液素/促胰液素受体轴的影响
  • 批准号:
    10676118
  • 财政年份:
    2020
  • 资助金额:
    $ 28.99万
  • 项目类别:
ShEEP Request for Leica Laser Capture Microdissection System (LMD7)
ShEEP 请求徕卡激光捕获显微切割系统 (LMD7)
  • 批准号:
    9908938
  • 财政年份:
    2019
  • 资助金额:
    $ 28.99万
  • 项目类别:
BLR&D Research Career Scientist Award
BLR
  • 批准号:
    10618284
  • 财政年份:
    2019
  • 资助金额:
    $ 28.99万
  • 项目类别:
BLR&D Research Career Scientist Award
BLR
  • 批准号:
    9763814
  • 财政年份:
    2019
  • 资助金额:
    $ 28.99万
  • 项目类别:
The Role of Stem Cell Derived Microvesicles in Cholestatic Liver Injury
干细胞衍生的微泡在胆汁淤积性肝损伤中的作用
  • 批准号:
    9930828
  • 财政年份:
    2019
  • 资助金额:
    $ 28.99万
  • 项目类别:

相似国自然基金

内源激动剂ArA靶向TMEM175蛋白缓解帕金森病症的分子机制研究
  • 批准号:
    32300565
  • 批准年份:
    2023
  • 资助金额:
    30 万元
  • 项目类别:
    青年科学基金项目
Adrb2激动剂在改善呼吸机相关性膈肌功能障碍中的作用与机制研究
  • 批准号:
    82372196
  • 批准年份:
    2023
  • 资助金额:
    49 万元
  • 项目类别:
    面上项目
新型IL2Rβγ激动剂逐级控释联合放疗对抗三阴性乳腺癌的作用及机制研究
  • 批准号:
    82303819
  • 批准年份:
    2023
  • 资助金额:
    30 万元
  • 项目类别:
    青年科学基金项目
基于OSMAC-GNPS分析策略的蚂蚱内生真菌Aspergillus sp.中新颖泛PPAR激动剂的发现及治疗NASH研究
  • 批准号:
    82304340
  • 批准年份:
    2023
  • 资助金额:
    30 万元
  • 项目类别:
    青年科学基金项目
探究FSP1激动剂在治疗肾缺血再灌注损伤中的分子机理与应用
  • 批准号:
    82304600
  • 批准年份:
    2023
  • 资助金额:
    30 万元
  • 项目类别:
    青年科学基金项目

相似海外基金

Discovery of GPR75 small molecule ligands for the treatment of obesity
发现用于治疗肥胖的 GPR75 小分子配体
  • 批准号:
    10697131
  • 财政年份:
    2023
  • 资助金额:
    $ 28.99万
  • 项目类别:
Role of CB1R expressed in the prefrontal cortex in the control of locomotion
前额皮质表达的 CB1R 在运动控制中的作用
  • 批准号:
    10590320
  • 财政年份:
    2023
  • 资助金额:
    $ 28.99万
  • 项目类别:
Exercise Mimetics for Dementia and Alzheimer's Disease
治疗痴呆和阿尔茨海默病的模拟运动
  • 批准号:
    10586188
  • 财政年份:
    2023
  • 资助金额:
    $ 28.99万
  • 项目类别:
Washington University SPORE in Pancreatic Cancer
华盛顿大学 SPORE 在胰腺癌中的应用
  • 批准号:
    10708572
  • 财政年份:
    2023
  • 资助金额:
    $ 28.99万
  • 项目类别:
Regulatory mechanisms of mitochondrial cristae biogenesis and thermogenic function
线粒体嵴生物发生和产热功能的调节机制
  • 批准号:
    10716595
  • 财政年份:
    2023
  • 资助金额:
    $ 28.99万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了